Novel Brain-Selective Conditional Knockout of the Norepinephrine Transporter

新型脑选择性条件性敲除去甲肾上腺素转运蛋白

基本信息

  • 批准号:
    8701598
  • 负责人:
  • 金额:
    $ 23.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-04 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The aim of this proposal is to develop novel mouse models that produce conditional knockout of the norepinephrine transporter (NET) gene. The overarching goal of this work is to elucidate the role of NET in central versus peripheral sympathetic nervous system (CNS vs. SNS) noradrenergic neurons to influence psychiatric phenotypes, and inspire new treatments for such disorders. Increasing evidence indicates significant comorbidities between brain and cardiovascular disorders. For example, patients with anxiety complain of heart palpitations and patients with tachycardia disorders have a higher incidence of anxiety. How these comorbidities derive from shared genetic risk factors is poorly understood. One shared component of circuits controlling mood and cardiovascular function is the neurotransmitter, norepinephrine (NE). NE released at synapses in the brain and heart is inactivated through active transport into terminals by the presynaptically- localized NET, making NET a critical mediator of NE inactivation and presynaptic catecholamine homeostasis. We have demonstrated that mice with a constitutive NET knockout or knock-in of a non-functional NET mutation, A457P, exhibit both tachycardia and anxiety. We have now generated the first mouse with a "floxed" NET allele to allow selective NET knockout to dissect CNS vs. SNS contributions to psychiatric disease. There has been little study to date of promoters that can drive expression in noradrenergic neurons selectively in the CNS versus SNS. This proposal will determine the ability of CRE driver lines to selectively knock out NET in central versus peripheral noradrenergic neurons. Aim I will cross CRE lines that reportedly drive recombination in either brain or SNS NE neurons with Rosa reporter mice and NET floxed mice. We will determine reporter expression, and NET expression and activity in the brain and SNS. Aim II will determine if anxiety/depression- related behaviors observed with constitutive manipulation of NET are driven by brain versus SNS NET. These studies introduce the novel scientific idea to use genetic dissection of brain versus SNS noradrenergic function, and provide a novel characterization of tools to accomplish this. These models will translate to the study of many other genes with tissue-specific expression in noradrenergic neurons. This work will allow us to more precisely understand the role of brain noradrenergic signaling in mental disorders.
描述(由申请人提供):本提案的目的是开发产生去甲肾上腺素转运蛋白(NET)基因条件性敲除的新型小鼠模型。这项工作的总体目标是阐明NET在中枢与外周交感神经系统(CNS与SNS)去甲肾上腺素能神经元中的作用,以影响精神病表型,并激发新的治疗方法。越来越多的证据表明脑和心血管疾病之间存在显著的共病。例如,焦虑症患者主诉心悸,心动过速障碍患者的焦虑发生率较高。这些合并症是如何从共同的遗传风险因素中衍生出来的,目前还知之甚少。控制情绪和心血管功能的电路的一个共享组件是神经递质,去甲肾上腺素(NE)。在脑和心脏中的突触处释放的NE通过由突触前定位的NET主动转运到终末而失活,使得NET成为NE失活和突触前儿茶酚胺稳态的关键介质。我们已经证明,组成性NET敲除或敲入非功能性NET突变A457 P的小鼠表现出心动过速和焦虑。我们现在已经产生了第一只具有“floxed”NET等位基因的小鼠,以允许选择性NET敲除来剖析CNS与SNS对精神疾病的贡献。迄今为止,很少有研究的启动子,可以驱动表达的去甲肾上腺素能神经元选择性地在中枢神经系统与SNS。该提议将确定CRE驱动线选择性地敲除中枢与外周去甲肾上腺素能神经元中的NET的能力。目的:我将CRE系与Rosa报告小鼠和NET floxed小鼠交叉,据报道,CRE系驱动脑或SNS NE神经元的重组。我们将确定报告基因的表达,以及NET在大脑和SNS中的表达和活性。目的二将确定是否焦虑/抑郁相关行为观察到的构成操纵的NET是由大脑与SNS NET。这些研究引入了新的科学思想,使用遗传解剖大脑与SNS去甲肾上腺素能功能,并提供了一种新的表征工具来实现这一点。这些模型将转化为去甲肾上腺素能神经元中具有组织特异性表达的许多其他基因的研究。这项工作将使我们能够更准确地了解大脑去甲肾上腺素能信号在精神障碍中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAUREEN K HAHN其他文献

MAUREEN K HAHN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAUREEN K HAHN', 18)}}的其他基金

Neurobehavioral Analysis of Norepinephrine Transporter Variants
去甲肾上腺素转运蛋白变体的神经行为分析
  • 批准号:
    7760087
  • 财政年份:
    2006
  • 资助金额:
    $ 23.5万
  • 项目类别:
Neurobehavioral Analysis of Norepinephrine Transporter Variants
去甲肾上腺素转运蛋白变体的神经行为分析
  • 批准号:
    7564751
  • 财政年份:
    2006
  • 资助金额:
    $ 23.5万
  • 项目类别:
Neurobehavioral Analysis of Norepinephrine Transporter Variants
去甲肾上腺素转运蛋白变体的神经行为分析
  • 批准号:
    7172648
  • 财政年份:
    2006
  • 资助金额:
    $ 23.5万
  • 项目类别:
Neurobehavioral Analysis of Norepinephrine Transporter Variants
去甲肾上腺素转运蛋白变体的神经行为分析
  • 批准号:
    7348289
  • 财政年份:
    2006
  • 资助金额:
    $ 23.5万
  • 项目类别:
Neurobehavioral Analysis of Norepinephrine Transporter
去甲肾上腺素转运蛋白的神经行为分析
  • 批准号:
    7022737
  • 财政年份:
    2006
  • 资助金额:
    $ 23.5万
  • 项目类别:
GENETIC POLYMORPHISMS HUMAN NOREPINEPHRINE TRANSPORTER
人类去甲肾上腺素转运蛋白基因多态性
  • 批准号:
    6477041
  • 财政年份:
    2001
  • 资助金额:
    $ 23.5万
  • 项目类别:
GENETIC POLYMORPHISMS HUMAN NOREPINEPHRINE TRANSPORTER
人类去甲肾上腺素转运蛋白基因多态性
  • 批准号:
    6209597
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 23.5万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 23.5万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 23.5万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 23.5万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 23.5万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 23.5万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 23.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了